Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

The latest news, stories and exciting findings from across the Oxford cancer research community

University's RadCam library highlighted in yellow
Julliet Lwiindi presents at the Oxford Cancer Pancreatic Cancer Networking Day

[Blog] The importance of PPI in basic, preclinical, and laboratory-based research.

At the recent Oxford Cancer Pancreatic Clinical Academic Networking Day, held on Wednesday 3 June 2026, Julliet Lwiindi, Oxford Cancer’s Public Engagement and Involvement Officer, spoke to delegates about Patient and Public Involvement (PPI) and the important role it can play in research.

Professor Adam Mead appointed as Director of Oxford Cancer

Oxford Cancer is delighted to announce the appointment of Professor Adam Mead as Director, joining Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.

Prostate cancer being highlighted in the body

Oxford researchers hunt for hidden protein clues to prevent prostate cancer

A major new research programme, led by Professor Ruth Travis and Dr Karl Smith-Byrne and funded by Cancer Research UK, aims to uncover the biological causes of prostate cancer and identify ways to prevent the disease.

First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford

Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.

Illustration of breast cancer highlighted on the body

Dr Ejung Moon awarded MRC funding to target metastatic breast cancer’s “Achilles’ heel”

Dr Ejung Moon, Group Leader in the University of Oxford’s Department of Oncology, has been awarded funding from the Medical Research Council (MRC) to investigate a promising new strategy for treating metastatic breast cancer.

Neutrophils in Cancer Networking Event Highlights Emerging Therapeutic Opportunities

Researchers, students, and industry representatives recently came together for 'Neutrophils in Cancer', an event organised by Oxford Cancer exploring the growing potential of neutrophil biology in cancer therapy.

New compound developed to target hypoxia by reducing tumour oxygen consumption

Researchers in the Departments of Oncology and Chemistry. have developed a promising new compound designed to reduce tumour hypoxia, a major cause of radiotherapy resistance.

Funding for research to investigate how certain cancers turn aggressive

Dr Srinivasa Rao and Dr Beatriz Gamez Molina receive a Cancer Research UK Early Detection and Diagnosis Primer award to improve early detection and prevention of progression in prostate cancer and multiple myeloma.

Three women from the Million Womens Study

World’s largest study of women’s health marks 30 years of pioneering research

Thirty years after its launch, the Million Women Study continues to shape evidence on HRT, cancer, ageing, and women’s health.

Dr Natalie Jooss named latest winner of CRUK's Research is Beautiful competition

Cancer Research UK's 'Research is Beautiful' image campaign highlights images that showcase cancer research.

Weighing scale and tape measure

Study reveals lifetime obesity exposure in cancer patients is widely underestimated

New data published today in ESMO Real World Data and Digital Oncology show that more than half of people receiving systemic anticancer treatment had a history of obesity, compared with only around one in four who were classified as obese at the time their treatment began.

Laptop and stethoscope

Oxford University Hospitals (OUH) NHS Foundation Trust joins €50m European study on heart health in cancer patients

Oxford University Hospitals (OUH) NHS Foundation Trust is one of the project partners and will receive €399,000 in funding. Daniel McGowan, Associate Professor in the Department of Oncology, University of Oxford, and Head of Education and Research in the Department of Medical Physics and Clinical Engineering at OUH, will lead the Oxford team in collaboration with GE HealthCare. Their research is focus on how they can adapt routine PET scans to also assess a patient’s heart health.

New Oxford-led study set to evaluate multi-cancer blood tests in GP practices for earlier diagnosis

In an advance for early cancer detection, a new Oxford-led study has received £3.6 million from the National Institute of Health and Care Research to evaluate breakthrough multi-cancer tests in NHS general practices. The research addresses a critical healthcare challenge: approximately half of all cancer patients initially visit their GP with vague, non-specific symptoms such as weight loss or abdominal pain, leading to dangerous delays in diagnosis and treatment.

White blood cell surrounded by red blood cells

Onima Chowdhury receives Cancer Research UK clinical trial grant

Congratulations to Dr Onima Chowdhury at the MRC Weatherall Institute of Molecular Medicine, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.

2026 Oxford Cancer Symposium showcases latest advances in the network's research and collaboration

Researchers and clinicians came together last week for the Oxford Cancer/Cancer Research UK (CRUK) Oxford Centre’s Annual Symposium, an event that continues to grow as a focal point for collaboration in cancer research across Oxford.

Prostate cancer being highlighted in the body

Funding for molecular tools to more precisely diagnose prostate cancer

Dr Pengfei Li and Dr Jonathan Wojciechowski receive a Cancer Research UK Early Detection and Diagnosis Primer Award to analyse modifications to PSA for early detection and phenotyping of prostate cancer.

Blood test tubes

Blood Test May Improve Survival of Childhood Cancer in Africa

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es salaam, Tanzania have shown that a minimally invasive “liquid biopsy” test can diagnose Burkitt lymphoma rapidly and accurately in sub-Saharan Africa, where delays in traditional testing often prove fatal.

Experts gather for the second annual Oxford Oesophagogastric Cancer Centre of Excellence Symposium

Our second annual Oxford Oesophagogastric Cancer Centre of Excellence Symposium took place on Friday 6 March, bringing together researchers and clinicians from across Oxford alongside external collaborators for a stimulating day of multidisciplinary discussion.

Oesophagal adenocarcinoma section visualised by multiplexed immunofluorescence, showing cell nuclei (greyscale) and micronuclei (aberrant nuclear structures formed when chromosomes are improperly segregated during cell division; red) interspersed throughout the malignant cell compartment (cyan). Infiltrating macrophages are shown in yellow.

New research reveals why some oesophageal cancers are so hard to treat

Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.

Paresh Vyas receives CRUK Discovery Programme Award

Congratulations to Professor Paresh Vyas in the MRC Weatherall Institute of Molecular Medicine, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.

Load More